These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6202756)

  • 1. Down regulation of RNA labeling as a selective marker for cytotoxic but not suppressor macrophages.
    Varesio L
    J Immunol; 1984 Jun; 132(6):2683-5. PubMed ID: 6202756
    [No Abstract]   [Full Text] [Related]  

  • 2. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokines inhibit macrophage RNA synthesis.
    Varesio L; Issaq HJ; Kowal R; Bonvini E; Taramelli D
    Cell Immunol; 1984 Mar; 84(1):51-64. PubMed ID: 6199124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional activities of the NCTC 1469 macrophage-like cell line: comparison of the NCTC 1469 cell line with various other macrophage-like cell lines.
    De Weger RA; Van Loveren H; Van Basten CD; Oskam R; Van Der Zeijst BA; Den Otter W
    J Reticuloendothel Soc; 1983 Jan; 33(1):55-66. PubMed ID: 6687612
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lymphokine production: II. Macrophage-dependent inhibition of production of macrophage activating factor.
    Varesio L; Holden HT; Taramelli D
    Cell Immunol; 1981 Sep; 63(2):279-92. PubMed ID: 6456076
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on mouse macrophage activation. II. Dissociation of the suppressive effects of macrophages on lymphocytes vs tumor cells].
    Sun DM; Shi W; Hu XZ; Lu S; Zhang YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):176-80. PubMed ID: 2939970
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of macrophage activity by 12-O-tetradecanoylphorbol-13-acetate.
    Gemsa D; Staar U; Grimm W; Hausmann G; Körner CF; Resch K; Krammer PH
    IARC Sci Publ; 1984; (56):319-36. PubMed ID: 6085623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and augmentation of guinea pig macrophages with streptococcal preparation OK-432 and stimulated spleen cell products.
    Onozaki K; Suzuki K; Fukutomi Y; Yagami K; Hashimoto T
    J Reticuloendothel Soc; 1982 Dec; 32(6):433-42. PubMed ID: 6761439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.
    Varesio L; Giovarelli M; Landolfo S; Forni G
    Cancer Res; 1979 Dec; 39(12):4983-8. PubMed ID: 159126
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences in the expression of a differentiation antigen of activated cells (ACA-1) on T killer cells and on MIF-producing cells].
    Nesterenko VG; Egorova SG; Suslov AP
    Biull Eksp Biol Med; 1983 Jan; 95(1):68-9. PubMed ID: 6338956
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines.
    Varesio L; Holden HT; Taramelli D
    J Immunol; 1980 Dec; 125(6):2810-7. PubMed ID: 6159423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.